Middle East and Africa Ocular Drug Delivery Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Middle East and Africa Ocular Drug Delivery Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Middle East and Africa Ocular Drug Delivery Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Middle East and Africa Ocular Drug Delivery Market Regional Analysis

6.2 Middle East and Africa Ocular Drug Delivery Market Revenue 2019-2028 (US$ Million)

6.3 Middle East and Africa Ocular Drug Delivery Market Forecast Analysis

7. Middle East and Africa Ocular Drug Delivery Market Analysis – by Technology

7.1 Implantable Ocular Drug Delivery Systems

7.1.1 Overview
7.1.2 Implantable Ocular Drug Delivery Systems: Middle East and Africa Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.2 Particulate Drug Delivery Systems

7.2.1 Overview
7.2.2 Particulate Drug Delivery Systems: Middle East and Africa Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.3 Nano-Particle Drug Delivery System

7.3.1 Overview
7.3.2 Nano-Particle Drug Delivery System: Middle East and Africa Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. Middle East and Africa Ocular Drug Delivery Market Analysis – by Formulation Type

8.1 Liposomes and Nanoparticles

8.1.1 Overview
8.1.2 Liposomes and Nanoparticles: Middle East and Africa Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.2 Solution

8.2.1 Overview
8.2.2 Solution: Middle East and Africa Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.3 Emulsion

8.3.1 Overview
8.3.2 Emulsion: Middle East and Africa Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.4 Suspension

8.4.1 Overview
8.4.2 Suspension: Middle East and Africa Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.5 Ointment

8.5.1 Overview
8.5.2 Ointment: Middle East and Africa Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. Middle East and Africa Ocular Drug Delivery Market Analysis – by Disease Type

9.1 Glaucoma

9.1.1 Overview
9.1.2 Glaucoma: Middle East and Africa Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.2 Diabetic Retinopathy

9.2.1 Overview
9.2.2 Diabetic Retinopathy: Middle East and Africa Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.3 Dry Eye Syndrome

9.3.1 Overview
9.3.2 Dry Eye Syndrome: Middle East and Africa Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.4 Macular Degeneration

9.4.1 Overview
9.4.2 Macular Degeneration: Middle East and Africa Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.5 Cataract

9.5.1 Overview
9.5.2 Cataract: Middle East and Africa Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.6 Diabetic Macular Edema

9.6.1 Overview
9.6.2 Diabetic Macular Edema: Middle East and Africa Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. Middle East and Africa Ocular Drug Delivery Market Analysis – by End User

10.1 Hospitals

10.1.1 Overview
10.1.2 Hospitals: Middle East and Africa Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)

10.2 Ophthalmic Clinics

10.2.1 Overview
10.2.2 Ophthalmic Clinics: Middle East and Africa Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)

10.3 Ambulatory Surgical Centers

10.3.1 Overview
10.3.2 Ambulatory Surgical Centers : Middle East and Africa Ocular Drug Delivery Market – Revenue and Forecast, 2019-2028 (US$ Million)

11. Middle East and Africa Ocular Drug Delivery Market – Middle East and Africa Analysis

11.1 Overview

11.2 Middle East and Africa

11.2.1 Middle East and Africa Ocular Drug Delivery Market Breakdown, by Key Country, 2022 and 2028 (%)
11.2.1.1 Middle East and Africa Ocular Drug Delivery Market – Revenue and Forecast Analysis – by Country
11.2.1.1 South Africa: Middle East and Africa Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.1.1 South Africa: Middle East and Africa Ocular Drug Delivery Market Breakdown, by Technology
11.2.1.1.2 South Africa: Middle East and Africa Ocular Drug Delivery Market Breakdown, by Formulation Type
11.2.1.1.3 South Africa: Middle East and Africa Ocular Drug Delivery Market Breakdown, by Disease Type
11.2.1.1.4 South Africa: Middle East and Africa Ocular Drug Delivery Market Breakdown, by End User

11.2.1.2 Saudi Arabia: Middle East and Africa Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.2.1 Saudi Arabia: Middle East and Africa Ocular Drug Delivery Market Breakdown, by Technology
11.2.1.2.2 Saudi Arabia: Middle East and Africa Ocular Drug Delivery Market Breakdown, by Formulation Type
11.2.1.2.3 Saudi Arabia: Middle East and Africa Ocular Drug Delivery Market Breakdown, by Disease Type
11.2.1.2.4 Saudi Arabia: Middle East and Africa Ocular Drug Delivery Market Breakdown, by End User

11.2.1.3 UAE: Middle East and Africa Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.3.1 UAE: Middle East and Africa Ocular Drug Delivery Market Breakdown, by Technology
11.2.1.3.2 UAE: Middle East and Africa Ocular Drug Delivery Market Breakdown, by Formulation Type
11.2.1.3.3 UAE: Middle East and Africa Ocular Drug Delivery Market Breakdown, by Disease Type
11.2.1.3.4 UAE: Middle East and Africa Ocular Drug Delivery Market Breakdown, by End User

11.2.1.4 Rest of Middle East and Africa: Middle East and Africa Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.4.1 Rest of Middle East and Africa: Middle East and Africa Ocular Drug Delivery Market Breakdown, by Technology
11.2.1.4.2 Rest of Middle East and Africa: Middle East and Africa Ocular Drug Delivery Market Breakdown, by Formulation Type
11.2.1.4.3 Rest of Middle East and Africa: Middle East and Africa Ocular Drug Delivery Market Breakdown, by Disease Type
11.2.1.4.4 Rest of Middle East and Africa: Middle East and Africa Ocular Drug Delivery Market Breakdown, by End User

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 AbbVie Inc.

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Bausch Health Companies Inc.

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Novartis AG

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Clearside Biomedical, Inc

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Alimera Sciences, Inc.

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Middle East and Africa Ocular Drug Delivery Market